PDS Biotechnology Statistics

Total Valuation

PDSB has a market cap or net worth of $77.25 million. The enterprise value is $56.23 million.

Market Cap	77.25M
Enterprise Value	56.23M

Important Dates

The last earnings date was Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

PDSB has 45.71 million shares outstanding. The number of shares has increased by 18.19% in one year.

Current Share Class	45.71M
Shares Outstanding	45.71M
Shares Change (YoY)	+18.19%
Shares Change (QoQ)	+8.09%
Owned by Insiders (%)	3.09%
Owned by Institutions (%)	8.88%
Float	39.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.43
P/TBV Ratio	3.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.85.

Current Ratio	2.33
Quick Ratio	2.19
Debt / Equity	0.85
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.98

Financial Efficiency

Return on equity (ROE) is -119.22% and return on invested capital (ROIC) is -43.04%.

Return on Equity (ROE)	-119.22%
Return on Assets (ROA)	-38.06%
Return on Invested Capital (ROIC)	-43.04%
Return on Capital Employed (ROCE)	-122.83%
Revenue Per Employee	n/a
Profits Per Employee	-$1.48M
Employee Count	24
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2.04M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.85% in the last 52 weeks. The beta is 1.24, so PDSB's price volatility has been higher than the market average.

Beta (5Y)	1.24
52-Week Price Change	-43.85%
50-Day Moving Average	1.28
200-Day Moving Average	2.03
Relative Strength Index (RSI)	64.38
Average Volume (20 Days)	848,813

Short Selling Information

The latest short interest is 2.88 million, so 6.29% of the outstanding shares have been sold short.

Short Interest	2.88M
Short Previous Month	2.97M
Short % of Shares Out	6.29%
Short % of Float	7.21%
Short Ratio (days to cover)	13.33

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-35.33M
Pretax Income	-45.29M
Net Income	-35.50M
EBITDA	-35.27M
EBIT	-35.33M
Earnings Per Share (EPS)	-$0.94

Full Income Statement

Balance Sheet

The company has $39.98 million in cash and $18.96 million in debt, giving a net cash position of $21.02 million or $0.46 per share.

Cash & Cash Equivalents	39.98M
Total Debt	18.96M
Net Cash	21.02M
Net Cash Per Share	$0.46
Equity (Book Value)	22.36M
Book Value Per Share	0.49
Working Capital	24.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$34.12 million and capital expenditures -$29,000, giving a free cash flow of -$34.15 million.

Operating Cash Flow	-34.12M
Capital Expenditures	-29,000
Free Cash Flow	-34.15M
FCF Per Share	-$0.75

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PDSB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.19%
Shareholder Yield	-18.19%
Earnings Yield	-45.95%
FCF Yield	-44.21%

Analyst Forecast

The average price target for PDSB is $10.00, which is 491.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	491.72%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 18, 2019. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Mar 18, 2019
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2